Bolt Biotherapeutics BOLT

$ 0.56 -1.58%

Quarterly report 2024-Q3
added 11-12-2024

Bolt Biotherapeutics Balance Sheet 2011-2024 | BOLT

Annual Balance Sheet Bolt Biotherapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	9.41 M	13.4 M	-3.03 M	3.83 M	-24.6 M	-13.6 M	-	-	-	-	-	-	-
Long Term Debt	17.4 M	20.2 M	21.9 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	2.78 M	2.39 M	2.5 M	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	329 K	85.6 M	29.2 M	-	-	-	-	-	-	-
Total Current Liabilities	20.5 M	23.1 M	21.3 M	-	-	-	-	-	-	-	-	-	-
Total Liabilities	47 M	56.3 M	57.6 M	46.2 M	94.3 M	31.9 M	-	-	-	-	-	-	-
Deferred Revenue	2.2 M	1.99 M	2.87 M	1.5 M	599 K	-	-	-	-	-	-	-	-
Retained Earnings	-364 M	-295 M	-207 M	-	-47.7 M	-17.2 M	-	-	-	-	-	-	-
Total Assets	160 M	228 M	308 M	46.5 M	48.4 M	16 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	10.8 M	9.24 M	27.4 M	-	-	-	-	-	-	-	-	-	-
Book Value	113 M	172 M	250 M	349 K	-45.8 M	-15.9 M	-	-	-	-	-	-	-
Total Shareholders Equity	113 M	172 M	250 M	-105 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Bolt Biotherapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	15.4 M	15.9 M	16.7 M	17.4 M	18.2 M	18.9 M	19.6 M	20.2 M	20.9 M	20.7 M	21.3 M	21.9 M	22.5 M	23.2 M	9.06 M	9.38 M	9.38 M	9.38 M	9.38 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	37.3 M	38.3 M	38.7 M	47 M	47.1 M	48.6 M	48.5 M	56.3 M	57.1 M	52.3 M	54.4 M	57.6 M	58.6 M	51.2 M	21.4 M	46.2 M	46.2 M	46.2 M	46.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	1.97 M	2.02 M	1.91 M	2.2 M	1.94 M	1.68 M	1.6 M	1.99 M	3.17 M	3.51 M	3.45 M	2.87 M	5.21 M	4.33 M	1.5 M	1.5 M	1.5 M	1.5 M	1.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-411 M	-396 M	-375 M	-364 M	-346 M	-330 M	-312 M	-295 M	-275 M	-253 M	-231 M	-207 M	-180 M	-156 M	-133 M	-108 M	-108 M	-108 M	-108 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	109 M	124 M	143 M	160 M	175 M	191 M	206 M	228 M	246 M	260 M	283 M	308 M	334 M	347 M	325 M	46.5 M	46.5 M	46.5 M	46.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	9.37 M	6.2 M	4.26 M	10.8 M	9.16 M	13.5 M	14.8 M	9.24 M	10.6 M	22.6 M	44 M	27.4 M	23.6 M	58.3 M	95.5 M	5.54 M	5.54 M	5.54 M	5.54 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	72 M	85.9 M	104 M	113 M	128 M	142 M	158 M	172 M	188 M	208 M	228 M	250 M	275 M	296 M	303 M	349 K	349 K	349 K	349 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	72 M	85.9 M	104 M	113 M	128 M	142 M	158 M	172 M	188 M	208 M	228 M	250 M	275 M	296 M	303 M	-105 M	-105 M	-105 M	-105 M	-45.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency